Cold & Cough Remedies - Zambia

  • Zambia
  • In Zambia, the revenue generated in the Cold & Cough Remedies market market amounts to US$4.10m in 2024.
  • It is projected that the market will experience an annual growth rate of 9.21% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States leads in terms of revenue generation, reaching US$11,190.00m in 2024.
  • In relation to the total population of Zambia, the per person revenue for Cold & Cough Remedies market in 2024 is US$0.19.
  • In Zambia, there is a growing demand for herbal-based cold and cough remedies due to the country's rich traditional medicine heritage.

Key regions: Australia, Japan, India, Brazil, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Zambia is experiencing steady growth due to increasing customer preferences for over-the-counter remedies, rising awareness about self-medication, and the local special circumstances in the country. Customer preferences in Zambia have shifted towards over-the-counter remedies for cold and cough. This can be attributed to the convenience and accessibility of these products, as customers can easily purchase them without a prescription. Additionally, the affordability of over-the-counter remedies compared to prescription medications is also a driving factor for customer preference. Furthermore, there is a growing awareness about self-medication among the population in Zambia. Customers are increasingly taking responsibility for their own health and seeking remedies for common ailments like cold and cough. This trend is driven by the desire to save time and money by avoiding visits to healthcare professionals for minor illnesses. In terms of trends in the market, there is a rising demand for natural and herbal cold and cough remedies in Zambia. Customers are becoming more conscious about the ingredients used in the products they consume and are opting for natural alternatives. This trend is in line with the global market, where there is a growing preference for natural and organic products. Another trend in the market is the introduction of innovative product formats. Cold and cough remedies are now available in various forms such as syrups, tablets, lozenges, and nasal sprays. This diversification of product formats caters to the different needs and preferences of customers, providing them with more options to choose from. Local special circumstances in Zambia also contribute to the development of the Cold & Cough Remedies market. The country has a high prevalence of respiratory infections, which leads to a higher demand for remedies to alleviate cold and cough symptoms. The changing weather patterns and the presence of dust and pollutants in the environment also contribute to the frequency of cold and cough cases, further driving the market growth. Underlying macroeconomic factors, such as the increasing disposable income and improving healthcare infrastructure in Zambia, also play a role in the development of the Cold & Cough Remedies market. As the economy grows, customers have more purchasing power to spend on healthcare products, including cold and cough remedies. Additionally, the improving healthcare infrastructure ensures better access to healthcare facilities and information, leading to increased awareness and demand for remedies. In conclusion, the Cold & Cough Remedies market in Zambia is developing due to customer preferences for over-the-counter remedies, rising awareness about self-medication, local special circumstances, and underlying macroeconomic factors. The market is witnessing trends such as the preference for natural remedies and the introduction of innovative product formats. These factors, combined with the high prevalence of respiratory infections and improving healthcare infrastructure, contribute to the steady growth of the market in Zambia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)